The Benchmark for Neurofilament Testing

Fully Automated Digital Immunoassay for Neurofilament Light Chain in Blood

Whitepaper

The Simoa Nf-L assay pioneered the measurement of neurofilament light chain in plasma and serum and has since been validated by hundreds of publications across numerous disease areas including Multiple Sclerosis (MS), Alzheimer's Disease (AD), Traumatic Brain Injury (TBI), and Amyotrophic lateral sclerosis (ALS).

With the support of large normative reference range databases, the Simoa Nf-L assay is suitable for clinical implementation as a laboratory-developed test. Download the whitepaper to learn more about the clinical implementation and use of the Simoa Nf-L test offered by Quanterix as a laboratory-developed test. Download the whitepaper to learn more.

If you see this, do not fill:

Fill in the form below.

First Name *
Last Name *
Email *
Company *
What type of organization is your company? *
Country *
State *
Postal Code *
Phone
I consent

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.